核心提示：2025年7月30日，据欧盟食品安全局（EFSA）消息，欧盟营养、新型食品和食物过敏原（NDA）研究小组就合成大麻二酚（synthetic cannabidiol）作为新型食品的安全性发表科学意见。……（世界食品网-www.shijieshipin.com）

2025年7月30日，据欧盟食品安全局（EFSA）消息，欧盟营养、新型食品和食物过敏原（NDA）研究小组就合成大麻二酚（synthetic cannabidiol）作为新型食品的安全性发表科学意见。
　　经过评估，专家小组得出结论，根据现有数据，无法确定合成大麻二酚作为新型食品的安全性。部分原文报道如下：

Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on synthetic cannabidiol as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The NF which is subject of the application is trans-cannabidiol (CBD), produced by chemical synthesis and proposed to be used in food supplements at a level of 30 mg/day. The target population is the general population, excluding pregnant and lactating women. During the risk assessment, the Panel identified a number of data gaps, which needed to be addressed by the applicant. Therefore, an EFSA request for additional information was sent to the applicant. The requested data concerned the identity, the production process, the compositional data, the specifications, the genotoxicity, the reproductive and developmental toxicity and the human data of the NF. Despite being contacted several times, the applicant did not reply to EFSA's requests for additional data. based on the available data, the Panel concludes that the safety of the NF, i.e. synthetic cannabidiol, cannot be established.